Brottem John L.'s Form 4 filing
Outset Medical, Inc. (OM) · filed Jan 22, 2025
- Accession no.
- 0001484612-25-000023
- Filed
- Jan 22, 2025
- Trade date
- Jan 17-21, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $26.3K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brottem John L.CIK 0001823381 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Common Stock | AGrant or awardAcquired | +9,090 | $0.00 | $0 | 214,118 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −777 | $0.80 | −$621.6 | 213,341 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −29,474 | $0.80 | −$23,579.2 | 183,867 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −2,679 | $0.80 | −$2,143.2 | 181,188 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.